Spatial patterns of mammalian brain aging: Distribution of cathepsin D-immunoreactive cell bodies and dystrophic dendrites in aging dogs resembles that in Alzheimer's disease

Journal of Comparative Neurology

Volumn 464, Issue 3, 2003, Pages 371-381

  Bi, Xiaoning ^a   Head, Elizabeth ^a   Cotman, Carl W ^a   Lynch, Gary ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hippocampus; Lysosome; Mammals; Neocortex; Neurodegeneration; Subiculum

Indexed keywords

CATHEPSIN D;

AGING; ALZHEIMER DISEASE; ARTICLE; DOG; FOREBRAIN; HIPPOCAMPUS; IMMUNOREACTIVITY; NEOCORTEX; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SUBICULUM;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; CATHEPSIN D; DENDRITES; DOGS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEUROAXONAL DYSTROPHIES; NEURONS; TISSUE DISTRIBUTION;

EID: 0043233071     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.10795     Document Type: Article

References (47)

1. Anderton BH, Callahan L, Coleman P, Davies P, Flood D, Jicha GA, Ohm T, Weaver C. 1998. Dendritic changes in Alzheimer's disease and factors that may underlie these changes. Prog Neurobiol 55:595-609.
2. Arendt T, Bruckner MK, Gertz HJ, Marcova L. 1998. Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodeling in the adult brain. Neuroscience 83:991-1002.
3. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. 1991. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1:103-116.
4. Ball MJ. 1977. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study. Acta Neuropathol (Berl) 37:111-118.
5. Bednarski E, Lynch G. 1996. Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L. J Neurochem 67:1846-1855.
6. Bi X, Haque T, Zhou J, Skillman AG, Lin B, Lee T, Kuntz ID, Ellman JA. 2000a. Novel cathepsin d inhibitors block the formation of hyperphosphorylated tau fragments in hippocampus. J Neurochem 74:1469-1477.
7. Bi X, Yong A, Zhou J, Gall CM, Lynch G. 2000b. Regionally selective changes in brain lysosomes occur in the transition from young adulthood to middle age in rats. Neuroscience 97:395-404.
8. Bi X, Yong AP, Zhou J, Ribak CE, Lynch G. 2001. Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 98:8832-8837.
9. Bobinski M, Wegiel J, Wisniewski HM, Tarnawski M, Reisberg B, De Leon MJ, Miller DC. 1996. Neurofibrillary pathology - correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol Aging 17:909-919.
10. Borras D, Ferrer I, Pumarola M. 1999. Age-related changes in the brain of the dog. Vet Pathol 36:202-211.
11. Braak H. 1984. Architectonics as seen by lipofuscin stains. In: Peters A, Jones EG, editors. Cerebral cortex. New York: Plenum Press. p 59-104.
12. Braak H, Braak E. 1985. On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease. Acta Neuropathol (Berl) 68:325-332.
13. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239-259.
14. Braak H, Del Tredici K, Schultz C, Braak E. 2000. Vulnerability of select neuronal types to Alzheimer's disease. Ann NY Acad Sci 924:53-61.
15. Brun A, Gustafson L. 1976. Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study. Arch Psychiatr Nervenkr 223:15-33.
16. Callahan LM, Vaules WA, Coleman PD. 1999. Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. J Neuropathol Exp Neurol 58:275-287.
17. Casanova MF, Carosella NW, Gold JM, Kleinman JE, Weinberger DR, Powers RE. 1993. A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia. Psychiatry Res 49:41-62.
18. Cataldo AM, Paskevich PA, Kominami E, Nixon RA. 1991. Lysosomal hydrolases of different classes are abnormally distributed in brain of patients with Alzheimer's disease. Proc Natl Acad Sci USA 88:10998-11002.
19. Colaco CA, Ledesma MD, Harrington CR, Avila J. 1996. The role of the Maillard reaction in other pathologies: Alzheimer's disease. Nephrol Dial Transplant 11:7-12.
20. Coleman PD, Flood DG. 1987. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging 8:521-545.
21. Colle MA, Hauw JJ, Crespeau F, Uchihara T, Akiyama H, Checler F, Pageat P, Duykaerts C. 2000. Vascular and parenchymal Abeta deposition in the aging dog: correlation with behavior. Neurobiol Aging 21:695-704.
22. Corder EH, Woodbury MA, Volkmann I, Madsen DK, Bogdanovic N, Winblad B. 2000. Density profiles of Alzheimer disease regional brain pathology for the huddinge brain bank: pattern recognition emulates and expands upon Braak staging. Exp Gerontol 35:851-864.
23. Cummings BJ, Head E, Afagh AJ, Milgram NW, Cotman CW. 1996. Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol Learn Mem 66:11-23.
24. Dei R, Takeda A, Niwa H, Li M, Nakagomi Y, Watanabe M, Inagaki T, Washimi Y, Yasuda Y, Horie K, Miyata T, Sobue G. 2002. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease. Acta Neuropathol (Berl) 104:113-122.
25. Dimakopoulos AC, Mayer RJ. 2002. Aspects of neurodegeneration in the canine brain. J Nutr 132:1579S-1582S.
26. Finch CE, Sapolsky RM. 1999. The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol Aging 20:407-428.
27. Flood DG, Guarnaccia M, Coleman PD. 1987. Dendritic extent in human CA2-3 hippocampal pyramidal neurons in normal aging and senile dementia. Brain Res 409:88-96.
28. Fukutani Y, Cairns NJ, Shiozawa M, Sasaki K, Sudo S, Isaki K, Lantos PL. 2000. Neuronal loss and neurofibrillary degeneration in the hippocampal cortex in late-onset sporadic Alzheimer's disease. Psychiatry Clin Neurosci 54:523-529.
29. Ginsberg SD, Hemby SE, Lee VM, Eberwine JH, Trojanowski JQ. 2000. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 48:77-87.
30. Head E, McCleary R, Hahn FF, Milgram NW, Cotman CW. 2000. Region-specific age at onset of beta-amyloid in dogs. Neurobiol Aging 21:89-96.
31. Head E, Milgram NW, Cotman C. 2001. Neurobiological models of aging in the dog and other vertebrate species. In: Hof P, Mobbs C, editors. Functional neurobiology of aging. New York: Academic Press. p 457-468.
32. Kenessey A, Nacharaju P, Ko LW, Yen SH. 1997. Degradation of tau by lysosomal enzyme cathepsin D: Implication for Alzheimer neurofibrillary degeneration. J Neurochem 69:2026-2038.
33. Munch G, Thome J, Foley P, Schinzel R, Riederer P. 1997. Advanced glycation endproducts in ageing and Alzheimer's disease. Brain Res Brain Res Rev 23:134-143.
34. Munch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ, Vlassara H, Smith MA, Perry G, Riederer P. 1998. Alzheimer's disease - synergistic effects of glucose deficit, oxidative stress and advanced glycation end-products. J Neural Transm 105:439-461.
35. Munch G, Shepherd CE, McCann H, Brooks WS, Kwok JB, Arendt T, Hallupp M, Schofield PR, Martins RN, Halliday GM. 2002. Intraneuronal advanced glycation endproducts in presenilin-1 Alzheimer's disease. Neuroreport 13:601-604.
36. Nakamura S, Tamaoka A, Sawamura N, Kiatipattanasakul W, Nakayama H, Shoji S, Yoshikawa Y, Doi K. 1997. Deposition of amyloid beta protein (A beta) subtypes [A beta 40 and A beta 42(43)] in canine senile plaques and cerebral amyloid angiopathy. Acta Neuropathol (Berl) 94:323-328.
37. Papaioannou N, Tooten PC, van Ederen AM, Bohl JR, Rofina J, Tsangaris T, Gruys E. 2001. Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques. Amyloid 8:11-21.
38. Shimada A, Kuwamura M, Umemura T, Takada K, Ohama E, Itakura C. 1991. Modified Bielschowsky and immunohistochemical studies on senile plaques in aged dogs. Neurosci Lett 129:25-28.
39. Shimada A, Kuwamura M, Awakura T, Umemura T, Takada K, Ohama E, Itakura C. 1992. Topographic relationship between senile plaques and cerebrovascular amyloidosis in the brain of aged dogs. J Vet Med Sci 54:137-144.
40. Takeda A, Wakai M, Niwa H, Dei R, Yamamoto M, Li M, Goto Y, Yasuda T, Nakagomi Y, Watanabe M, Inagaki T, Yasuda Y, Miyata T, Sobue G. 2001. Neuronal and glial advanced glycation end product [Nepsilon-(carboxymethyl)lysine]] in Alzheimer's disease brains. Acta Neuropathol (Berl) 101:27-35.
41. Thorpe SR, Baynes JW. 1996. Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging 9:69-77.
42. Torp R, Head E, Milgram NW, Hahn F, Ottersen OP, Cotman CW. 2000. Ultrastructural evidence of fibrillar beta-amyloid associated with neuronal membranes in behaviorally characterized aged dog brains. Neuroscience 96:495-506.
43. Troncoso JC, Cataldo AM, Nixon RA, Barnett JL, Lee MK, Checler F, Fowler DR, Smialek JE, Crain B, Martin LJ, Kawas CH. 1998. Neuropathology of preclinical and clinical later-onset Alzheimer's disease. Ann. Neurol. 43:673-676.
44. Weber K, Schmahl W, Munch G. 1998. Distribution of advanced glycation end products in the cerebellar neurons of dogs. Brain Res 791:11-17.
45. Wegiel J, Wisniewski HM, Dziewiatkowski J, Tarnawski M, Nowakowski J, Dziewiatkowska A, Soltysiak Z. 1995. The origin of amyloid in cerebral vessels of aged dogs. Brain Res 705:225-234.
46. Weldon DT, Maggio JE, Mantyh PW. 1997. New insights into the neuropathology and cell biology of Alzheimer's disease. Geriatrics 52:S13-16.
47. Yang AJ, Chandswangbhuvana D, Margol L, Glabe CG. 1998. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J Neurosci Res 52:691-698.